For Southeastern United States FamiliesDiabetic Foot Ulcer Treatment in Cuba in Southeastern United States
The Southeastern United States — including Florida, Mississippi, Louisiana, South Carolina, and neighboring states — is home to over 1.1 million Americans living with Alzheimer's. This region has some of the highest Alzheimer's prevalence rates in the nation, driven by large senior populations, significant African American communities (who face disproportionately high dementia risk), and high diabetes rates that compound cognitive decline. Miami, Tampa, and Fort Lauderdale offer the most convenient direct charter flights to Havana, while Atlanta, Charlotte, and New Orleans provide connecting flight options.
7.0M
Southeastern United States residents with diabetes
6
states in region
1–5 hours (varies by departure city)
to Havana
Direct
flights available
Heberprot-P for Diabetic Foot Ulcers Across Southeastern United States
Heberprot-P is Cuba's pioneering treatment for diabetic foot ulcers. Developed by the Center for Genetic Engineering and Biotechnology (CIGB), it contains recombinant human epidermal growth factor (rEGF) — a protein that stimulates cell growth and new blood vessel formation in wounds. It is administered via intralesional injection directly into the ulcer bed, typically 3 times per week, combined with surgical debridement and specialized dressings.
Heberprot-P is not FDA-approved and is not available in the United States. It is registered in approximately 20 countries and has been used in Cuba for over a decade. The treatment is designed for chronic diabetic foot ulcers — particularly Wagner grade 1–3 ulcers that have not responded to standard wound care (debridement, off-loading, moisture dressings) after 4+ weeks.
The treatment program at Cuban diabetic foot centers includes comprehensive vascular assessment (Doppler, angiography if indicated), infection management (wound cultures, targeted antibiotics), surgical debridement, Heberprot-P intralesional injections, off-loading (total contact casting or specialized footwear), specialized dressings, and rehabilitation. The goal is wound healing and amputation prevention — not a cure for diabetes. Treatment suitability is determined after individual medical evaluation.
Heberprot-P is not FDA-approved and is not available in the United States. It is not a cure for diabetes. Treatment aims to promote wound healing and prevent amputation. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.
State-by-State Guides
Diabetic Foot Ulcer Treatment in Cuba by State in Southeastern United States
Select your state for detailed information about diabetic foot ulcer treatment in cuba options, travel logistics, and state-specific resources.
City-Level Guides
Diabetic Foot Ulcer Treatment in Cuba by City in Southeastern United States
Travel from Southeastern United States
Getting to Havana from Southeastern United States
Major Departure Airports
- Miami (MIA)
- Tampa (TPA)
- Fort Lauderdale (FLL)
- Atlanta (ATL)
- Charlotte (CLT)
- New Orleans (MSY)
Travel time: 1–5 hours (varies by departure city)
Travel Authorization
- • U.S. citizens can travel to Cuba under approved categories
- • SMC Salud provides letter of medical necessity
- • Treatment confirmation documentation included
- • Airport reception and ground transport in Havana
- • English-speaking coordinators throughout your stay
Frequently Asked Questions
Questions from Southeastern United States Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Diabetic Foot Ulcer Treatment in Cuba in Cuba?
Submit your medical records for a complimentary review. Families across Southeastern United States receive a personalized treatment proposal within 5–10 business days.